All In MedTech

Device Trial Radar · NCT02800863

TARGET Post-Approval Study

TARGET: A Post-Approval Study to Evaluate Targeted SCS Spinal Cord Stimulation (SCS) Dorsal Root Ganglion (DRG) Stimulation for the Management of Moderate to Severe Chronic, Intractable, Pain of the Lower Limbs Due to CRPS Types I and II

Last checked: Nov 20, 2026Latest source record: Jul 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

426

Actual

Start

Aug 23, 2016

Primary completion

Sep 23, 2021

Study completion Sep 23, 2021

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
Jun 15, 2016

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 22 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this prospective, multicenter, single arm post-approval study is to demonstrate continued safety of the Axium and Proclaim Neurostimulator System for dorsal root ganglion (DRG) stimulation. The primary endpoint is the 12-month serious adverse event rate for permanent implants.

Conditions

  • Complex Regional Pain Syndrome (CRPS)

Interventions

  • Dorsal Root Ganglion (DRG) Stimulation (Axium™ Neurostimulator System)Device

    Electrical stimulation of the DRG using the Axium™ Neurostimulator System

  • Dorsal Root Ganglion (DRG) Stimulation (Proclaim™ Neurostimulator System)Device

    Electrical Stimulation of the DRG using the Proclaim™ Neurostimulator System.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Serious Adverse Events (SAEs)Time frame: throughout 12 month study

Locations

44 sites in 1 country. Site status is shown where the registry gives one.

  • Arizona Pain Specialists

    Scottsdale, Arizona

  • Spanish Hills Interventional Pain Specialists

    Camarillo, California

  • California Orthopedics & Spine

    Larkspur, California

41 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.